Weekly newsletter

Small quantities of coronavirus vaccines could arrive in Hungary already this month, but mass vaccination can start in 2021, a National Public Health Centre (NNK) official said on Monday. According to the Prime Minister, frontline healthcare staff will be inoculated in the first phase, followed by patients with chronic illnesses.

Ágnes Galgóczi, head of the epidemiology department, told a press conference that Hungary had contracted 17.5 million doses of vaccines from various manufacturers. The licensing procedure of the vaccines is continually being monitored, she said.

Coronavirus Vaccine: Registration Needed Otherwise Last on the List?
Coronavirus Vaccine: Registration Needed Otherwise Last on the List?

Last week, the pre-registration for the coronavirus vaccine began on a new official government website. However, in recent days, neither the government nor the operative board has been clear on what exactly it means to register at vakcinainfo.gov.hu and whether those who apply will be able to choose from the available vaccines. At the same […]Continue reading

Since Pfizer’s vaccine is most likely to be approved by the European Medicines Agency the soonest, it will be the first product to be used for mass vaccination in Hungary, she added.

Orbán: First doses of vaccines expected in late December

Hungary’s operative board coordinating response to the epidemic has prepared a national vaccination action plan, Prime Minister Viktor Orbán said in parliament on Monday, noting that vaccination will be voluntary and available free of charge.

In the first phase, frontline health-care staff will be inoculated, followed by patients with chronic illnesses, he said.

“Every life matters; we have concluded a contract with every serious vaccine producer,” the prime minister said.

'Remdesivir is Clearly Helping People' - Interview with Richter CEO Gábor Orbán
'Remdesivir is Clearly Helping People' - Interview with Richter CEO Gábor Orbán

“Remdesivir can cut the duration of hospital stay by 3-5 days,” Gábor Orbán, CEO of major Hungarian pharmaceutical company Gedeon Richter, told Hungary Today in an exclusive interview. Orbán discussed the pandemic, the drug remdesivir, the issue of vaccination and social trust, and what we learnt from the crisis. When did you first hear about […]Continue reading

Current coronavirus regulations must, however, be maintained until vaccinations can begin, he said.

featured image illustration via Attila Balázs/MTI